Introduction
Several, mainly epidemiological, observations suggest that one or more viruses are involved in the etiology of multiple sclerosis (MS) [13, 5, 
18].
Unlike in subacute sclerosing panencephalitis (SSPE) or progressive rubella panencephalitis (PRP), in which typical antibody patterns and viral persistence in the central nervous system (CNS) are observed, in MS no one virus has emerged from virological studies as the etiological agent. With the exception of some controversial reports [4, 7, 15, 3] viruses have not been isolated from the CNS of MS patients and the antibody findings are not highly characteristic. However, since Adams and Imagawa [1] observed increased measles titers in patients with MS, many studies have been made on the behavior of antibodies against measles and other viruses in the serum and cerebrospinal fluid (CSF) of such patients [17] . Paramyxoviruses have been more thoroughly investigated than others because of the similarities of the viral envelope to the plasma membrane of the host cells [2] . We report here the results of titrations of antibodies to mumps, rubella, Sendal and Herpes simplex viruses in the sera and CSF of MS patients and healthy controls. Data on the measles antibodies in the same groups of patients and controls have already been published [61.
Subjects and methods
Specimens. Sera were collected from 176 MS patients and CSF from 48 of them. In all cases the clinical diagnosis was confirmed at the Multiple Sclerosis Research Center, Gallarate (VA), according to the criteria of McDonald and Holliday/16/. Sera from 150 healthy controls in the 20-50 year age range were also tested.
Antibody assay. Sera and CSF specimens were assayed for hemaglutination inhibition (h.i.e.) to mumps, Sendal (murine parainfluenza type 1 and rubella viruses and for complement fixing antibody (c,f.a.) to herpes simplex and to the s antigen of mumps and Sendal viruses. As source of antigen in the rubella h.i. test and in the herpes simplex c.f. test commercial preparations were used; h.i. and soluble complement fixing antigens to mumps and Sendai viruses were pre-pared in embryonated eggs according to the method indicated for mumps virus [8] . Antibody titrations were performed with the microtiter technique according to standard procedures [11]. 2 fold dihltions of sera starting from 1:4 were tested in c.f. test. Aspecific hemagglutination inhibitors to mumps and Sendai viruses were removed from the sera by treatment with RDE (Receptor Destroyng Enzyme), those to rubella virus by treatment with heparin manganous chloride. Starting dilutions of sera were 1 : 5 in h.i. test for the former viruses and 1:8 for the latter. CSF specimens were checked undiluted and in 2 fold dilutions.
Results
Results of viral antibodies titration in the sera of MS patients and controls are presented in Table  1 as percentage of positives and geometric mean titres (GMT). MS patients have been divided into two groups: those treated with immunosuppressive drugs and those not so treated. In the computation of the GMT subjects who were negative for the specific viral antigen were assigned the titer of the next lowest dilution. No difference in GMT was found in three groups under study. The prevalence of subjects with mumps h.i.e. was significantly higher among patients, both treated and untreated, than in controls (P < 0,001 -X 2 test). Moreover MS patients had a higher prevalence of CF serum antibodies against herpes simplex virus then controls (0,01>P>0,001) but the difference is statistically significant for the treated patients (0,01>P>0,001), not for the untreated ones (P>0,05). CSF from 48 MS patients were also tested for viral antibodies and only one was found positive: CF antibodies to herpes simplex virus were detectable in the undiluted specimen.
Discussion
There has been little ar no direct evidence of the involvement of one or more viral agents in the etiopatogenisis of MS. It is therefore not surprising that a lot of emphasis has been put on attempts to gain indirect evidence through seroepidemiological investigations. As a part of a wide-ranging study on the relationship between viruses and MS, viral antibodies were preliminarily checked in the sera of 176 patients and in a suitable control group of healthy adults. After measles [6] , other enveloped viruses, namely mumps, Sendal, rubella and herpes simplex were considered. For the two paramyxoviruses, besides antibodies against the surface antigen haemoagglutinin, antibodies against the internal antigens were also titrated. That because the persistence of paramyxovirus-like nucleocapsids in CNS cells have alrealdy been proved in other chronic neurological disorders [14] and, by some authors, also in MS [15] . As in other similar investigations evaluation of results is rather difficult. Differences between MS patients and controls were found only in the prevalence of h.i.a, against mumps and of c.f.a. a-gainst herpes simplex, both in favour of the patients. But a further analysis of the data shows that, for herpes simplex, but not for mumps, only patients treated with immunosuppressive drugs had statistically higher antibody prevalence than controls. Incidentally also the only patient, out of 48, who had c.f.a, to herpes simplex in CSF belonged to the treated group. This finding suggests caution in evaluating antibody results to viruses undergoing reactivation, like 
